BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16150697)

  • 1. Macromolecular translocation inhibitor II (Zn(2+)-binding protein, parathymosin) interacts with the glucocorticoid receptor and enhances transcription in vivo.
    Okamoto K; Isohashi F
    J Biol Chem; 2005 Nov; 280(44):36986-93. PubMed ID: 16150697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and primary structure of a macromolecular-translocation inhibitor II of glucocorticoid-receptor binding to nuclei from rat liver. Inhibitor II is the 11.5-kDa Zn2+-binding protein (parathymosin).
    Okamoto K; Isohashi F
    Eur J Biochem; 2000 Jan; 267(1):155-62. PubMed ID: 10601862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Small Nuclear Acidic Protein (MTI-II, Zn
    Okamoto K; Hirata-Tsuchiya S; Kitamura C; Omoteyama K; Sato T; Arito M; Kurokawa MS; Suematsu N; Kato T
    Endocrinology; 2016 Dec; 157(12):4973-4986. PubMed ID: 27740872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of macromolecular-translocation inhibitor-III on binding of activated glucocorticoid-receptor complex to specific DNA.
    Okamoto K; Liu G; Yu WG; Ochiai T; Isohashi F
    J Biochem; 1996 May; 119(5):920-5. PubMed ID: 8797092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear-receptor interacting protein (RIP) 140 binds to the human glucocorticoid receptor and modulates hormone-dependent transactivation.
    Windahl SH; Treuter E; Ford J; Zilliacus J; Gustafsson JA; McEwan IJ
    J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):93-102. PubMed ID: 10659697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flightless-I homolog regulates glucocorticoid receptor-mediated transcription via direct interaction of the leucine-rich repeat domain.
    Jin HL; Yang L; Jeong KW
    Mol Biol Rep; 2017 Apr; 44(2):243-250. PubMed ID: 28455686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recruitment of p160 coactivators by glucocorticoid receptor between Schwann cells and astrocytes.
    Grenier J; Trousson A; Chauchereau A; Cartaud J; Schumacher M; Massaad C
    Mol Endocrinol; 2006 Feb; 20(2):254-67. PubMed ID: 16179382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
    Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
    Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription.
    Chen S; Sarlis NJ; Simons SS
    J Biol Chem; 2000 Sep; 275(39):30106-17. PubMed ID: 10899170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small nuclear acidic protein (MTI-II, Zn
    Hirata-Tsuchiya S; Suzuki S; Okamoto K; Saito N; Yuan H; Yamada S; Jimi E; Shiba H; Kitamura C
    Mol Cell Biochem; 2020 Jun; 469(1-2):133-142. PubMed ID: 32304006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.
    Deroo BJ; Rentsch C; Sampath S; Young J; DeFranco DB; Archer TK
    Mol Cell Biol; 2002 Jun; 22(12):4113-23. PubMed ID: 12024025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.
    Shimizu N; Ouchida R; Yoshikawa N; Hisada T; Watanabe H; Okamoto K; Kusuhara M; Handa H; Morimoto C; Tanaka H
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8555-60. PubMed ID: 15941832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
    Bamberger CM; Wald M; Bamberger AM; Schulte HM
    Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.
    Martini PG; Delage-Mourroux R; Kraichely DM; Katzenellenbogen BS
    Mol Cell Biol; 2000 Sep; 20(17):6224-32. PubMed ID: 10938099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants.
    Nishi M; Ogawa H; Ito T; Matsuda KI; Kawata M
    Mol Endocrinol; 2001 Jul; 15(7):1077-92. PubMed ID: 11435609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid.
    Miura T; Ouchida R; Yoshikawa N; Okamoto K; Makino Y; Nakamura T; Morimoto C; Makino I; Tanaka H
    J Biol Chem; 2001 Dec; 276(50):47371-8. PubMed ID: 11577102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Shah YM; Rowan BG
    Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression.
    Kodama T; Shimizu N; Yoshikawa N; Makino Y; Ouchida R; Okamoto K; Hisada T; Nakamura H; Morimoto C; Tanaka H
    J Biol Chem; 2003 Aug; 278(35):33384-91. PubMed ID: 12810720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
    Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
    J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.